▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2120 by analyst upside · 2026-11-13
PRVA
Privia Health Group, Inc.
Healthcare · Market Cap $3B · P/E 91.0x
ANALYST PRICE TARGET
+32.5%
implied upside to consensus target
Current Price $23.67
Consensus Target $31.35
Bull Target $38.0
Bear Target $24.0
Analysts Covering 17
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
11
Hold
1
Sell
0
52-Week Low $18.91
52-Week High $28.82
YTD Return +0.9%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) 91.0x
Forward P/E 23.0x
EPS (TTM) $0.26
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.4B
Profit Margin 1.4%
52-WEEK RANGE
52-Week Low $18.91
52-Week High $28.82
Current Price $23.67
Bear Target $24.0
Bull Target $38.0
● Now $23.67 ● Target $31.35
TRADING DATA
Avg Volume 1.2M
YTD Return +0.9%
Analyst Count 17
Consensus Buy
Upside to Target +32.5%
Last Updated 2026-11-13

ANALYST SUMMARY

Privia Health Group, Inc. (PRVA) is currently trading at $23.67 with a Wall Street consensus price target of $31.35, implying potential upside of 32.5% over the next 12 months. 17 analysts currently cover PRVA, with a consensus rating of Buy - 94% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $38.0, while the most cautious has a target of $24.0.

PRVA operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 0.9% year-to-date and is currently trading near the lower end of its 52-week range of $18.91 – $28.82.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PRVA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-11-06 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-11-06 14% win rate (7 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-26 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-05-08 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-08 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-03-25 Building track record
Citigroup - Reiterated
Buy → Buy 2026-03-03 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-03-02 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
22/30
Consensus clarity
18/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →